Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Other Non-Current Assets (2011 - 2026)

Updated

Atossa Therapeutics (ATOS) reported Other Non-Current Assets of $1.27 million for Q2 2026, down 36.4% from $2 million a year earlier and down 0.3% from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Other Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Atossa Therapeutics posted Other Non-Current Assets of $1.99 million, up 0.2% from FY2024.

  • Other Non-Current Assets has a five-year compound annual growth rate of 159.2% (FY2020 to FY2025).
  • By year, Other Non-Current Assets came in at $1.99 million in FY2024 (-14.5%), $2.32 million in FY2023 (+265.8%), $635,000 in FY2022 and $22,000 in FY2021 (+29.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets since Q2 2023.
  • Year over year, Other Non-Current Assets gained in two of the last eight quarters, with an average decline of 14.8%.
  • The high point for year-over-year Other Non-Current Assets in five years was Q2 2024 (growth of 278.5%); the low point was Q2 2026 (a decline of 36.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.28 million (Q1 2026), $1.99 million (Q4 2025) and $2.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - 1.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.27 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.99 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 2.00 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 2.37 Mn
Jun 30, 2024 2.43 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 2.32 Mn
Sep 30, 2023 2.34 Mn
Jun 30, 2023 642,000.00
Mar 31, 2023 631,000.00
Dec 31, 2022 635,000.00
Sep 30, 2022 629,000.00
Jun 30, 2022 627,000.00
Mar 31, 2022 630,000.00
Dec 31, 2021 22,000.00
Sep 30, 2021 14,218.00
API Access

Atossa Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY